Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

News
Tracking Cost of Care Discussions Between Physicians and Patients with NSCLC and Melanoma
10/30/2023

Grace Taylor

Grace Taylor
Robin Yabroff, PhD, MBA, and Michael T. Halpern, MD, PhD, MPH, examine the documentation of cost of care discussions between physicians and patients with non–small cell lung cancer and melanoma.
Robin Yabroff, PhD, MBA, and Michael T. Halpern, MD, PhD, MPH, examine the documentation of cost of care discussions between physicians and patients with non–small cell lung cancer and melanoma.
Robin Yabroff, PhD, MBA, and...
10/30/2023
Journal of Clinical Pathways
News
Do Medically Integrated Pharmacies Reduce the Abandonment Rate of Oral Anticancer Medications?
10/30/2023

Emry Lloyd

Emry Lloyd
Dr Doshi and colleagues measured the impact of medically integrated pharmacies on prescription medication abandonment rates.
Dr Doshi and colleagues measured the impact of medically integrated pharmacies on prescription medication abandonment rates.
Dr Doshi and colleagues measured...
10/30/2023
Journal of Clinical Pathways
News
The Impact of Lower Cost Alternatives or Biosimilars on The Cost of Key Cancer Drugs
10/28/2023

Grace Taylor

Grace Taylor
Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.
Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.
Puneeth Indurlal, MD, MS, and...
10/28/2023
Journal of Clinical Pathways
News
How Well Does the Enhancing Oncology Model Capture Treatment Costs in Disease Groups?
10/27/2023

Emry Lloyd

Emry Lloyd
Katherine Baker, MD, and colleagues investigated how the Enhancing Oncology Model captures the performance risk and treatment costs within a disease.
Katherine Baker, MD, and colleagues investigated how the Enhancing Oncology Model captures the performance risk and treatment costs within a disease.
Katherine Baker, MD, and...
10/27/2023
Journal of Clinical Pathways
News
The Impact of Dosing Approaches for Lenalidomide on Total Cost of Care
10/27/2023

Grace Taylor

Grace Taylor
Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.
Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.
Puneeth Indurlal, MD, MS, The US...
10/27/2023
Journal of Clinical Pathways
News
Access to Pediatric Palliative Care Assessed in Resource-Constrained Communities
10/27/2023

Emry Lloyd

Emry Lloyd
Dr Houston and colleagues assessed the care capacity and improvement strategies of pediatric institutions that care for children with cancer.
Dr Houston and colleagues assessed the care capacity and improvement strategies of pediatric institutions that care for children with cancer.
Dr Houston and colleagues...
10/27/2023
Journal of Clinical Pathways
News
Rollback of Prescription Delivery Flexibilities Poses Challenges for At-Risk Cancer Patients
10/27/2023

Brandon Twyford

Brandon Twyford
Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.
Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.
Research presented at the 2023...
10/27/2023
Journal of Clinical Pathways
News
The Influence of End-of-Life Care Costs on Episodic Value-Based Care Models
10/26/2023

Emry Lloyd

Emry Lloyd
In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.
In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.
In this study, Gunjan Sharma,...
10/26/2023
Journal of Clinical Pathways
News
Virtual Consult Pilot Successfully Implemented in Integrated Health System
10/26/2023

Brandon Twyford

Brandon Twyford
An innovative virtual consult pilot launched by Kaiser Permanente saw success in bridging the gap between oncologists and cancer subspecialists within the organization.
An innovative virtual consult pilot launched by Kaiser Permanente saw success in bridging the gap between oncologists and cancer subspecialists within the organization.
An innovative virtual consult...
10/26/2023
Journal of Clinical Pathways
News
Outpatient Chemotherapy Safety Improved Through a Multidisciplinary Quality Improvement Program
10/26/2023

Brandon Twyford

Brandon Twyford
In this study, high alarm rates from ambulatory chemotherapy pumps that caused disruptions in dose deliveries were analyzed and a quality improvement program was initiated to address concerns over safe delivery of chemotherapy to patients.
In this study, high alarm rates from ambulatory chemotherapy pumps that caused disruptions in dose deliveries were analyzed and a quality improvement program was initiated to address concerns over safe delivery of chemotherapy to patients.
In this study, high alarm rates...
10/26/2023
Journal of Clinical Pathways
News
Shift to Oral Anti-Cancer Drugs Impacting OCM: Study Shows Rise in Part D Drug Expenses
10/26/2023

Brandon Twyford

Brandon Twyford
Researchers examined the impact of the shift toward oral anti-cancer drugs and the consequent rise in costs within the Oncology Care Model. The abstract was presented at the 2023 ASCO Quality Care Symposium in Boston, Massachusetts.
Researchers examined the impact of the shift toward oral anti-cancer drugs and the consequent rise in costs within the Oncology Care Model. The abstract was presented at the 2023 ASCO Quality Care Symposium in Boston, Massachusetts.
Researchers examined the impact...
10/26/2023
Journal of Clinical Pathways
News
The Travel Oncology Workforce and its Impact on Patient Access in Rural Areas in the US
10/25/2023

Grace Taylor

Grace Taylor
A recent study by Bruno Scodari, MD, and colleagues characterized oncologists who travel to rural areas to provide more access to cancer care and examined the effectiveness of this outreach method in reducing travel burden on patients.
A recent study by Bruno Scodari, MD, and colleagues characterized oncologists who travel to rural areas to provide more access to cancer care and examined the effectiveness of this outreach method in reducing travel burden on patients.
A recent study by Bruno Scodari,...
10/25/2023
Journal of Clinical Pathways
News
Strategic Operational Changes Improve Patient Access to Oncology Care
10/25/2023

Brandon Twyford

Brandon Twyford
An abstract presented at the 2023 ASCO Quality Care Symposium evaluated the impact of a quality improvement initiative to increase patient access to care and improve the overall patient experience.
An abstract presented at the 2023 ASCO Quality Care Symposium evaluated the impact of a quality improvement initiative to increase patient access to care and improve the overall patient experience.
An abstract presented at the...
10/25/2023
Journal of Clinical Pathways
Conference Coverage
Testing Hospital-Based Financial Toxicity Interventions at Memorial Sloan Kettering Cancer Center
10/01/2022

Marta Rybczynski

Marta Rybczynski
At least a quarter of patients at Memorial Sloan Kettering Cancer Center suffer with financial difficulties related to cancer treatment, suggesting a need for systems-based interventions to proactively assess financial toxicity risk and refer...
At least a quarter of patients at Memorial Sloan Kettering Cancer Center suffer with financial difficulties related to cancer treatment, suggesting a need for systems-based interventions to proactively assess financial toxicity risk and refer...
At least a quarter of patients...
10/01/2022
Journal of Clinical Pathways
Conference Coverage
Therapeutic Interchange Reduces Cost While Maintaining Quality of Care in the US Oncology Care Model
10/01/2022

Katie Herman

Katie Herman
At the 2022 ASCO Quality Care Symposium, Ives and colleagues concluded that therapeutic interchange is an effective way to reduce total cost of care while maintaining the quality of care in the Oncology Care Model.
At the 2022 ASCO Quality Care Symposium, Ives and colleagues concluded that therapeutic interchange is an effective way to reduce total cost of care while maintaining the quality of care in the Oncology Care Model.
At the 2022 ASCO Quality Care...
10/01/2022
Journal of Clinical Pathways
Conference Coverage
Outcomes Among Patients Treated With Immune Checkpoint Inhibitors in the Inpatient Setting
09/30/2022

Marta Rybczynski

Marta Rybczynski
Clinical outcomes from a multi-institutional study analyzing patient outcomes following inpatient immune checkpoint inhibitor therapy may “give clinicians pause” when considering inpatient immune checkpoint inhibitor use, according to a study...
Clinical outcomes from a multi-institutional study analyzing patient outcomes following inpatient immune checkpoint inhibitor therapy may “give clinicians pause” when considering inpatient immune checkpoint inhibitor use, according to a study...
Clinical outcomes from a...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
Pathway Compliance Linked to First-Line Treatment Regimen
09/30/2022

Craig Ostroff

Craig Ostroff
Pathway compliance was observed in almost two-thirds of cases among patients with metastatic disease who were treated in the first-line setting, according to a presentation at the 2022 ASCO Quality Care Symposium. Due to increasing health...
Pathway compliance was observed in almost two-thirds of cases among patients with metastatic disease who were treated in the first-line setting, according to a presentation at the 2022 ASCO Quality Care Symposium. Due to increasing health...
Pathway compliance was observed...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
Evaluating Cost Savings of Collaborative Cancer-Patient Navigation Program Compared to Embedded Programs
09/30/2022

Craig Ostroff

Craig Ostroff
Cancer-patient navigation programs tend to reduce total costs of care and improve outcomes. This study, presented at the 2022 ASCO Quality Care Symposium, explored whether an independent cancer-patient navigation program in collaboration with...
Cancer-patient navigation programs tend to reduce total costs of care and improve outcomes. This study, presented at the 2022 ASCO Quality Care Symposium, explored whether an independent cancer-patient navigation program in collaboration with...
Cancer-patient navigation...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
Assessing the Impact of COVID-19 on Prescribing Patterns in Multiple Myeloma
09/30/2022

Marta Rybczynski

Marta Rybczynski
While the total number of new therapy starts in multiple myeloma (MM) decreased during COVID-19, the rate of new starts for both intravenous and oral therapies in MM significantly increased, according to study findings presented at the 2022...
While the total number of new therapy starts in multiple myeloma (MM) decreased during COVID-19, the rate of new starts for both intravenous and oral therapies in MM significantly increased, according to study findings presented at the 2022...
While the total number of new...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
PRO-Based Symptom Management Shows Links to Improved Clinical Outcomes
09/30/2022

Craig Ostroff

Craig Ostroff
Randomized controlled trials at academic medical centers have shown an improvement in clinical outcomes when utilizing patient-reported outcome-based symptom management solutions, according to a presentation at the 2022 ASCO Quality Care...
Randomized controlled trials at academic medical centers have shown an improvement in clinical outcomes when utilizing patient-reported outcome-based symptom management solutions, according to a presentation at the 2022 ASCO Quality Care...
Randomized controlled trials at...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
EFI an Objective, Standardized Approach Option to Frailty in Colorectal Cancer
09/30/2022
Traditional frailty indices are not widely utilized in clinical oncology. According to a presentation at the 2022 ASCO Quality Care Symposium, an EFI created from electronic medical records can be utilized as an objective, standardized...
Traditional frailty indices are not widely utilized in clinical oncology. According to a presentation at the 2022 ASCO Quality Care Symposium, an EFI created from electronic medical records can be utilized as an objective, standardized...
Traditional frailty indices are...
09/30/2022
Journal of Clinical Pathways
Sarah Temkin, MD
Videos
Survey Aims to Inform Quality Improvement Initiatives in Ovarian Cancer Care Programs
11/01/2021
Sarah Temkin, MD, discusses a national survey of ovarian cancer care programs in the United States, identifying the needs of patients and informing quality improvement initiatives for these programs.
Sarah Temkin, MD, discusses a national survey of ovarian cancer care programs in the United States, identifying the needs of patients and informing quality improvement initiatives for these programs.
Sarah Temkin, MD, discusses a...
11/01/2021
Journal of Clinical Pathways
Conference Coverage
Treatment Preferences for Relapsed/Refractory MM in Later Lines of Therapy
10/07/2021

Marta Rybczynski

Marta Rybczynski
Findings from a recent study revealed that oncologists place higher relative importance on OS, PFS, and ORR, and prefer a decreased risk of grade 3/4 keratopathy and thrombocytopenia when choosing later line therapies in relapsed/refractory...
Findings from a recent study revealed that oncologists place higher relative importance on OS, PFS, and ORR, and prefer a decreased risk of grade 3/4 keratopathy and thrombocytopenia when choosing later line therapies in relapsed/refractory...
Findings from a recent study...
10/07/2021
Journal of Clinical Pathways
Conference Coverage
HRQOL With Nivolumab Plus Chemo vs Chemo Alone Among Patients With Gastrointestinal Cancers
10/04/2021

Marta Rybczynski

Marta Rybczynski
Compared with chemotherapy alone, nivolumab added to chemotherapy maintained health-related quality of life with a decreased risk of symptom deterioration in patients with previously untreated advanced or metastatic gastric...
Compared with chemotherapy alone, nivolumab added to chemotherapy maintained health-related quality of life with a decreased risk of symptom deterioration in patients with previously untreated advanced or metastatic gastric...
Compared with chemotherapy...
10/04/2021
Journal of Clinical Pathways
Conference Coverage
Trends in Total and Out-of-Pocket Cost Among Privately Insured Patients With Cancer
10/04/2021

Marta Rybczynski

Marta Rybczynski
The rise in cancer treatment costs in combination with the increase of cost-sharing have financially burdened privately insured, nonelderly patients with cancer.
The rise in cancer treatment costs in combination with the increase of cost-sharing have financially burdened privately insured, nonelderly patients with cancer.
The rise in cancer treatment...
10/04/2021
Journal of Clinical Pathways
Conference Coverage
Cost-Related Medication Nonadherence Among Cancer Survivors in Rural and Urban Settings
10/04/2021

Marta Rybczynski

Marta Rybczynski
According to a study presented at the 2021 ASCO Quality Care Symposium, cost-related prescription nonadherence is associated with higher health care cost responsibility in cancer survivors, especially for those living in rural compared to...
According to a study presented at the 2021 ASCO Quality Care Symposium, cost-related prescription nonadherence is associated with higher health care cost responsibility in cancer survivors, especially for those living in rural compared to...
According to a study presented...
10/04/2021
Journal of Clinical Pathways
Conference Coverage
Changes in PROs Can Predict Treatment Response and Survival in Metastatic Gastrointestinal Cancer
10/04/2021

Marta Rybczynski

Marta Rybczynski
Results from a study presented at the 2021 ASCO Quality Care Symposium showed that 1-month changes in patient-reported outcomes predicted treatment responses and survival outcomes among patients with metastatic GI cancer.
Results from a study presented at the 2021 ASCO Quality Care Symposium showed that 1-month changes in patient-reported outcomes predicted treatment responses and survival outcomes among patients with metastatic GI cancer.
Results from a study presented...
10/04/2021
Journal of Clinical Pathways

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement